Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China
· Delayed Price · Currency is CNY 17.67
+1.45 (8.94%)
Mar 10, 2026, 3:00 PM CST
Jiangsu Aidea Pharmaceutical Group Company Description
Jiangsu Aidea Pharmaceutical Group Co., Ltd. develops, produces, and sells pharmaceutical products in China and internationally.
The company offers anti-virus products, such as ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and baicillus cereus tablets.
It also exports its products. The company was formerly known as Jiangsu Aidea Pharmaceutical Co., Ltd. and changed its name to Jiangsu Aidea Pharmaceutical Group Co., Ltd. in July 2025.
The company was founded in 2009 and is headquartered in Yangzhou, China.
Jiangsu Aidea Pharmaceutical Group Co., Ltd.
| Country | China |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 683 |
| CEO | Jie Zhang |
Contact Details
Address: No. 69, Xinganquan West Road Yangzhou, 225008 China | |
| Phone | 86 514 8753 0666 |
| Website | aidea.com.cn |
Stock Details
| Ticker Symbol | 688488 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000041S6 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jie Zhang | Chief Executive Officer, President and Director |
| Chuanhong Zhu | Financial Director and Accounting Supervisor |
| Guang Rong Wang | Vice President and Director |
| Gaohong Gu | Senior Vice President |
| Yan Liu | Secretary of the Board |
| Hong Qin | Vice President |
| Tie Sun | Director of Pharmacology and Toxicology and Senior Director of Biologics Research & Development |
| Qide Li | Director of Pharmaceutical Research Institute |
| Jibing Zhang | Factory Manager of Human Protein |
| Yu Yuan | Quality Center Director |